Conference Call Scheduled for Today, February 3, 2021, at 3:30 PM CT (4:30 PM ET) Revenues of $64.2 million increased 6% sequentially compared to first quarter Net loss was $0.1 million, or $0.00 per basic and diluted share Management provides fiscal 2021 third quarter revenue guidance of $60 million to […]
Financial
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2020
Reports Fourth Quarter Revenues of $11.1 Billion; Full-Year Revenues of $42.5 Billion Posts Fourth Quarter Loss Per Share of $4.45 and Non-GAAP EPS of $1.46; Full-Year Loss Per Share of $3.99 and Non-GAAP EPS of $6.44 Completes Acquisition of MyoKardia, Expanding Leading Cardiovascular Franchise Announces Debt Tender Offer for an […]
Merck Announces Fourth-Quarter and Full-Year 2020 Financial Results
Fourth-Quarter 2020 Worldwide Sales Were $12.5 Billion, an Increase of 5% Fourth-Quarter 2020 GAAP Loss per Share Was $0.83, Reflecting Charges Related to Acquisitions and Intangible Asset Impairments; Fourth-Quarter Non-GAAP EPS Was $1.32 Full-Year 2020 Worldwide Sales Were $48.0 Billion, an Increase of 2%; Excluding the Impact from Foreign Exchange, […]
Quanterix Prices Public Offering of Common Stock
BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (Nasdaq: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the pricing of its previously announced underwritten public offering of 3,571,428 shares of its common stock at a public offering price of $70.00 per share. All of the shares in […]
Acceleron Announces Fourth Quarter and Full Year 2020 REBLOZYL® Net Sales
– Acceleron expects to report approximately $23.0 million in royalty revenue for Q4 2020 from approximately $115 million in net sales of REBLOZYL® (luspatercept-aamt) as reported by Bristol Myers Squibb – – Acceleron expects to report approximately $54.8 million in royalty revenue for full year 2020 from approximately $274 million in […]
Boston Scientific Announces Results For Fourth Quarter And Full Year 2020
MARLBOROUGH, Mass., Feb. 3, 2021 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.708 billion during the fourth quarter of 2020. This represents a decline of (6.8) percent on a reported basis, (8.3) percent on an operational1 basis and (8.0) percent on an organic2 basis, all compared to the prior year period. Included […]
Amgen Reports Fourth Quarter And Full Year 2020 Financial Results
THOUSAND OAKS, Calif., Feb. 2, 2021 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year 2020 versus comparable periods in 2019. Key results include: For the fourth quarter, total revenues increased 7% to $6.6 billion in comparison to the fourth quarter of 2019, driven by higher volume growth, partially […]
Angioplasty Scoring & Microcatheter Company Series A Oversubscribed
SALT LAKE CITY, Feb. 3, 2021 /PRNewswire/ — Transit Scientific today announced the close of its Series A financing round. The round was led by a large multinational investor and joined by previous seed investors. Transit Scientific achieved FDA clearances and multi-center, multi-user, safe-patient-use of its XO Score angioplasty scoring-cutting platform and […]
SpectraWAVE Announces $13.2 Million Series A-2 Financing from Existing Investors to Bring Intracoronary Imaging Technology to Market
Funds will accelerate development and support regulatory filing BEDFORD, Mass.–(BUSINESS WIRE)–SpectraWAVE, Inc. today announced a $13.2 million Series A-2 financing to support completion of product development and regulatory filing for its flagship intracoronary imaging product, designed to help physicians optimize coronary stenting interventions and limit future adverse events. The funding […]
CVR Medical Corp. Plans Addition to Board of Directors
Vancouver, British Columbia–(Newsfile Corp. – February 2, 2021) – CVR Medical Corp. (TSXV: CVM) (OTC: CRRVF) (“CVR Medical” or the “Company” or “we“) a Canadian listed and US based healthcare company in the medical device market intends to diversify its’ Directors which is subject to approval at the Annual Shareholders’ Meeting. Harvey […]
Recent
New HFSA Scientific Statement Provides Practical Guidance for Managing Heart Failure with Mildly Reduced Ejection Fraction
Sonorous Neurovascular Receives FDA 510(k) Clearance for BosCATH™ Neurovascular Catheter
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
Popular
- No commented posts yet